Patientricity offer tailor-made solutions for biopharma companies tapping into the Japanese market.
As your trusted partner, Patientricity provide virtual management consulting services in Japan with both scientific and operational expertise, helping you register and launch your innovative products and build your Japan business successfully on your own terms.
What Patientricity advise is based on evidence and experience directly working in the industry. With that, you can make well-informed decisions and virtually and successfully manage product launch in Japan without you investing in your own direct organization at an initial stage.
Market size and growth potential
Treatment landscape and trends
KOL & patient insights
Key stakeholder mapping
Market entry strategy
Clinical Development & Regulatory Affairs
Regulatory & clinical development road map
PMDA & MHWL interactions
Oversight of clinical programs (CRO or vendor management)
Pricing & reimbursement strategy
Patient engagement strategy
KOL mapping & engagement
Data gap analysis and data generation
Medical Advisory Board
Scientific communication platform
Compliance and governance
Why choose Patientricity ?
We are passionate about serving patients and improve the quality of healthcare. This helps us craft a patient-centric solution to challenges in competitive
With leadership experiences in pharmaceuticals, we understand what’s critical and matters for your business. We are committed to deliver for your success.
We have an extensive local network of industrial leaders, medical practioners and patients. This positions us uniquely and allows us to procede our business with a strong sense of purpose.
Integrity and quality are two basic foundations that we value. As professionals we take pride in what we do and strive to meet and go beyond your expectations.
Partial list of completed projects
Competitive intelligence on marketing for epilepsy products in Japan – Global pharma
Advisory for laying out pre-launch medical activities for successful launch in Japan - Global pharma
Market research on acute myelogenous leukemia treatment landscape, competitive analysis and clinical insights in Japan – Global megapharma
Qualitative research (Japanese KOL interviews) for an innovative product for castration resistant prostate cancer – US biotech
Advisory for Medical Affairs roles & responsibilities and organizational structures for product launch in the area of specialty care in Japan – top-tier consulting company
Advisory for pharmacovigilance requirements for FDA/EMA – top-tier consulting company
Advisory for best practices in Medical Information, MSL and Medical Affairs – global consulting company